Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 - ...

Ascherio said the university was able to pull together funding to pay his researchers’ salaries until next June. But he’s ...

Many diseases affect men and women differently. Asthma tends to strike men earlier in life, yet more women develop asthma as ...

"Driven by urgent unmet needs and scientific advances, the Alzheimer's Disease DMT market is poised for rapid growth as pharmaceutical companies shift their focus to multi-target therapies that ...

The dad and motorcycle racer thought his lack of coordination was from being tired. It was an early ALS symptom. Now, he's ...

The transcranial doppler market is projected to grow at a 5.89% CAGR from 2025 to 2032, driven by rising traumatic brain injuries, neurological disorders, and sports-related injuries. Advances in AI ...

The Pennsylvania Commonwealth Court, in a recent published decision, Fee v. Prospect Medical Holdings (Workers’ Compensation ...

Call Scheduled for August 14, 2025, at 8:30 AM Eastern Time ...

Migraines are not just “bad headaches”; they are a complex neurological condition that can take different forms, often ...

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in ...